BASFI is a better indicator of low quality of life than BASDAI in ankylosing spondylitis

results from the Scotland and Ireland Registry for Ankylosing Spondylitis (SIRAS)

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)621-621
Number of pages1
JournalClinical and Experimental Rheumatology
Volume30
Issue number4
Publication statusPublished - Jul 2012

Cite this

@article{deb82c509ce5487186246bbdf6c5969e,
title = "BASFI is a better indicator of low quality of life than BASDAI in ankylosing spondylitis: results from the Scotland and Ireland Registry for Ankylosing Spondylitis (SIRAS)",
author = "Dean, {L E} and Macfarlane, {G J} and Jones, {G T} and SIRAS",
year = "2012",
month = "7",
language = "English",
volume = "30",
pages = "621--621",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "CLINICAL & EXPER RHEUMATOLOGY",
number = "4",

}

TY - JOUR

T1 - BASFI is a better indicator of low quality of life than BASDAI in ankylosing spondylitis

T2 - results from the Scotland and Ireland Registry for Ankylosing Spondylitis (SIRAS)

AU - Dean, L E

AU - Macfarlane, G J

AU - Jones, G T

AU - SIRAS

PY - 2012/7

Y1 - 2012/7

M3 - Abstract

VL - 30

SP - 621

EP - 621

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 4

ER -